Search research articles
Contact Us
Filters
Showing results (21-30 of 619) with videos related to
Page
of 62
Sort By:
Current Opinion in Immunology
|
February 27, 1999
Antigen presentation by MHC class I and its regulation by interferon gamma
K Früh, Y Yang
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2026
Corrigendum to "Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19)" [Eur J Cancer 2025 Nov 29:232:116138]
A Addeo, M Früh
Sudhoffs Archiv
|
January 1, 1992
["Preformation and prediction" of the human sex. Wilhelm Weinberg's critique of Otto Schöner's "theory"]
J Süss, D Früh
Cancer Cell
|
May 16, 2018
Genomic Features of Response to Combination Immunotherapy in Lung Cancer
Martin Früh, Solange Peters
Angewandte Chemie (International Ed. in English)
|
August 23, 2014
Vanadium-catalyzed solvent-free synthesis of quaternary α-trifluoromethyl nitriles by electrophilic trifluoromethylation
Natalja Früh, Antonio Togni
Journal of General Microbiology
|
July 1, 1981
Properties and localization of N-acetylglutamate deacetylase from Pseudomonas aeruginosa
H Früh, T Leisinger
Traffic (Copenhagen, Denmark)
|
February 24, 2001
Control of MHC class I traffic from the endoplasmic reticulum by cellular chaperones and viral anti-chaperones
A Gruhler, K Früh
Journal of Medical Internet Research
|
March 10, 2020
Technological, Organizational, and Environmental Factors Influencing Social Media Adoption by Hospitals in Switzerland: Cross-Sectional Study
Michael Beier, Sebastian Früh
Brain & Spine
|
October 17, 2022
Macrovascular decompression of a dolichoectatic vertebral artery via Kawase approach in a patient suffering from trigeminal neuralgia - A case report
Anton Früh, Peter Vajkoczy
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 15, 2019
EGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in non-small-cell lung cancer
M Früh, S Peters
Page
of 62
Search research articles
Search
Showing results (21-30 of 619) with videos related to
Sort By:
Page
of 62
Current Opinion in Immunology
|
February 27, 1999
Antigen presentation by MHC class I and its regulation by interferon gamma
K Früh, Y Yang
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2026
Corrigendum to "Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19)" [Eur J Cancer 2025 Nov 29:232:116138]
A Addeo, M Früh
Sudhoffs Archiv
|
January 1, 1992
["Preformation and prediction" of the human sex. Wilhelm Weinberg's critique of Otto Schöner's "theory"]
J Süss, D Früh
Cancer Cell
|
May 16, 2018
Genomic Features of Response to Combination Immunotherapy in Lung Cancer
Martin Früh, Solange Peters
Angewandte Chemie (International Ed. in English)
|
August 23, 2014
Vanadium-catalyzed solvent-free synthesis of quaternary α-trifluoromethyl nitriles by electrophilic trifluoromethylation
Natalja Früh, Antonio Togni
Journal of General Microbiology
|
July 1, 1981
Properties and localization of N-acetylglutamate deacetylase from Pseudomonas aeruginosa
H Früh, T Leisinger
Traffic (Copenhagen, Denmark)
|
February 24, 2001
Control of MHC class I traffic from the endoplasmic reticulum by cellular chaperones and viral anti-chaperones
A Gruhler, K Früh
Journal of Medical Internet Research
|
March 10, 2020
Technological, Organizational, and Environmental Factors Influencing Social Media Adoption by Hospitals in Switzerland: Cross-Sectional Study
Michael Beier, Sebastian Früh
Brain & Spine
|
October 17, 2022
Macrovascular decompression of a dolichoectatic vertebral artery via Kawase approach in a patient suffering from trigeminal neuralgia - A case report
Anton Früh, Peter Vajkoczy
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 15, 2019
EGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in non-small-cell lung cancer
M Früh, S Peters
Page
of 62